the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Japan urges China to act after travel warning in Taiwan dispute

Japan asks China to take appropriate measures after Beijing discouraged citizens from visiting Japan amid tensions over Taiwan comments.

TOKYO: Japan urged China on Saturday to take “appropriate measures” after Beijing warned Chinese citizens against visiting Japan, Kyodo news agency reported, in an ongoing dispute over Taiwan.

Chief Cabinet Secretary Minoru Kihara said Japan had “conveyed the message to China and strongly asked it to take appropriate actions,” the report said. It did not quote him as elaborating on the measures.

China on Friday cautioned its citizens against visiting Japan in the spat sparked by comments from Japanese Prime Minister Sanae Takaichi. She said last week that a Chinese attack on Taiwan could amount to a “survival-threatening situation”, potentially triggering a military response from Tokyo.

ALSO READ: China warns Japan will face crushing defeat over Taiwan intervention

Kihara said Japan and China differ on the issue and it was vital to maintain communication, Kyodo reported.

China claims democratically governed Taiwan and has not ruled out using force to take control of the island, which sits just 110 km (70 miles) from Japanese territory. Taiwan’s government rejects Beijing’s sovereignty claims.

Japanese leaders have previously avoided publicly mentioning Taiwan when discussing such scenarios, maintaining a “strategic ambiguity” also favoured by Tokyo’s main security ally, the United States. – Reuters

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings